Lilit Karapetyan
- Oncology top 10%
- Immunology top 10%
- Molecular Biology
- Pulmonary and Respiratory Medicine
- Cancer Research
- Co-authors
- John M. KirkwoodAndrew KnightJason J. LukeDiwakar DavarDario A.A. VignaliCreg J. WorkmanAnthony R. CilloLawrence P. Andrews
- Topics
- Cancer Immunotherapy and Biomarkers (12 papers)CAR-T cell therapy research (10 papers)Immunotherapy and Immune Responses (9 papers)
- Partner nations
- United StatesJordanChina
In The Last Decade
Lilit Karapetyan
34 papers receiving 534 citations
Hit Papers
Peers
Comparison fields: 5 of 80
- Oncology 326
- Immunology 258
- Molecular Biology 133
- Pulmonary and Respiratory Medicine 83
- Cancer Research 37
Countries citing papers authored by Lilit Karapetyan
This map shows the geographic impact of Lilit Karapetyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lilit Karapetyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lilit Karapetyan more than expected).
Fields of papers citing papers by Lilit Karapetyan
This network shows the impact of papers produced by Lilit Karapetyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lilit Karapetyan. The network helps show where Lilit Karapetyan may publish in the future.
Co-authorship network of co-authors of Lilit Karapetyan
This figure shows the co-authorship network connecting the top 25 collaborators of Lilit Karapetyan. A scholar is included among the top collaborators of Lilit Karapetyan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lilit Karapetyan. Lilit Karapetyan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 5 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | Blockade of LAG-3 and PD-1 leads to co-expression of cytotoxic and exhaustion gene modules in CD8+ T cells to promote antitumor immunitybreakdown → | 75 |
| 7 | 5 | |
| 8 | 1 | |
| 9 | 9 | |
| 10 | 19 | |
| 11 | 12 | |
| 12 | Immunotherapy in Melanoma: Recent Advances and Future Directionsbreakdown → | 125 |
| 13 | Acral melanoma: clinical advances and hope for the future. | 3 |
| 14 | 71 | |
| 15 | 3 | |
| 16 | Toll-Like Receptor 9 Agonists in Cancer | 2 |
| 17 | 5 | |
| 18 | 16 | |
| 19 | 14 | |
| 20 | 2 |
About Lilit Karapetyan
Lilit Karapetyan is a scholar working on Oncology, Immunology and Otorhinolaryngology, having authored 35 papers that have together received 542 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (12 papers), CAR-T cell therapy research (10 papers) and Immunotherapy and Immune Responses (9 papers). The work is most often cited by research in Immunology (258 citations), Oncology (326 citations) and Otorhinolaryngology (15 citations). Lilit Karapetyan has collaborated with scholars based in United States, Jordan and China. Frequent co-authors include John M. Kirkwood, Andrew Knight, Jason J. Luke, Diwakar Davar, Dario A.A. Vignali, Creg J. Workman, Anthony R. Cillo, Lawrence P. Andrews, Cindy Sander and Arivarasan Karunamurthy. Their work appears in journals such as Cell, Journal of Clinical Investigation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.